SYRESpyre Therapeutics, Inc.

$90.61

Is it safe?

Can SYRE take a bad year?

The deepest fall in SYRE's price history on file is −99%; it is 17% below its high today.

72.06

Altman Z-score · distress below 1.8 · safe above 3 · safe zone, the balance sheet is not what threatens this one

Annualised volatility
69%

Annualised volatility · three times the market's own swing

Worst drawdown on file
−99%

Worst drawdown on file · −17% today

Details
Cash and short-term investments
$1.15B
Operating profit, trailing twelve months
−$201M
Annualised volatilitytwo years of daily moves
69%
Worst drawdown on file
−99%
Below its 52-week high
17%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.